Clinical Trials Browser

Phase 1 × Terminated × IFL protocol × Clear all

Advanced Solid Tumor

NCT04553692 2025-03-28

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers

GastrointestinalLymphoidOther hematologic neoplasmSarcoma

Chondrosarcoma, Lymphoma, Non-Hodgkin, Neoplasm Metastasis, Sarcoma, Colorectal Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute

NCT05084859 2024-08-09

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

Phase 1 Terminated

30 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT03035253 2020-08-11

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

Phase 1 Terminated

16 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT02726334 2019-01-16

A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.

Phase 1 Terminated

22 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00719199 2013-10-22

Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer

Phase 1 Terminated

21 enrolled

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

Clinical Trials

MINOTAUR

Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer.

Study of FOLFIRI Plus Cetuximab Plus IMO-2055 in Patients With Colorectal Cancer